Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): Collagen disorders and musculo-skeletal disorders

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue 2, 1999, Pages 141-145

  Bankowski, Zbigniew ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Fracture pathological; Lupus erythematosus syndrome; Myositis; Osteoporosis; Retroperitoneal fibrosis; Vasculitis

Indexed keywords

ARTICLE; COLLAGEN DISEASE; DRUG SURVEILLANCE PROGRAM; MUSCULOSKELETAL DISEASE; MYOSITIS; NOMENCLATURE; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 0345643383     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199903/04)8:2<141::AID-PDS410>3.0.CO;2-X     Document Type: Article

References (14)

1. International Reporting of Adverse Drug Reactions. Final Report of CIOMS Working Group, CIOMS, Geneva, 1990.
2. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an International Consensus Meeting. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990; 28(8): 317-322.
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29(2): 75-81.
4. Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism. Pharmacoepidemiol. Drug Safety 1992; 1: 39-45.
5. Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis. Pharmacoepidemiol. Drug Safety 1992; 1: 133-137.
6. Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis. Pharmacoepidemiol. Drug Safety 1992; 1: 191-196.
7. Basic requirements for the use of terms for reporting adverse drug reactions (IV). Diskinesia, depression, myopathy, neuropathy, paralysis, convulsions. Pharmacoepidemiol. Drug Safety 1993; 2: 149-153.
8. Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder, acidosis. Pharmacoepidemiol. Drug Safety 1993; 2: 189-193.
9. Definitions of adverse drug reactions and minimum requirements for their use: cardiovascular disease terms. Pharmacoepidemiol. Drug Safety 1993; 2: 591-602.
10. Harmonizing the use of adverse-drug-reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders. Pharmacoepidemiol. Drug Safety 1997; 6: 115-127.
11. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders. Pharmacoepidemiol. Drug Safety 1997; 6: 203-211.
12. Basic requirements for the use of terms for reporting adverse drug reactions (IX). Nervous system and psychiatric disorders. Pharmacoepidemiol. Drug Safety 1998; 7: 39-49.
13. Basic requirements for the use of terms for reporting adverse drug reactions (X). Gastrointestinal system disorders. Pharmacoepidemiol. Drug Safety 1998; 7: 281-287.
14. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): Cardiovascular system disorders. Pharmacoepidemiol. Drug Safety 1998; 7: 351-357.